A new challenge for the patent system
Research into stem cells is leading to new demands on the patent system - and provoking resistance from protesters. Members of FICPI's Biotech Committee Helene Fagerlin, David Bannerman, Lola Bartoszewicz and Danny Huntington survey the latest developments in the US, Europe and elsewhere
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
